Islamabad - Dr Mohammed Aslam has assumed the charge of chief executive officer of the Drug Regulatory Authority of Pakistan.

He is the first CEO appointed in line with the DRAP Act 2012 after fulfilling all requirements and formalities. Prior to this appointment Arshad Khan, director legal affairs of DRAP, was looking after the day-to-day work of CEO DRAP. The position was also held in the past by a senior joint secretary and an ex-director general health on temporary and additional charge basis. Appointment of a regular full-time incumbent to head this key organisation was a long-standing legal requirement and demand of stakeholders including the industry being critical to the optimal functioning of an organisation regulating one of the country’s largest industries.

The appointment was made through open advertisement. The applications received were forwarded to the commission for appointment of heads of federal government bodies. The short listing was carried out in a highly transparent manner by M/s Ferguson. Dr Muhammed Aslam was placed at the top position in the short listing by M/s Ferguson and was subsequently endorsed by the policy board of DRAP comprising representatives of all provinces. The recommendation was then forwarded for formal approval of the prime minister.

Dr Muhammed Aslam is seen as an accomplished professional in the field of pharmaceuticals and has been associated in the past with the industry. He had resigned from his work in the Pharma industry, which was also a prerequisite for appointment as CEO DRAP.